Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Doesn't everyone think Brad Robinson owes all us shareholders an update?
It is crazy to think posters like Anthazar can represent past CEO's on this board and provide more information than the company itself provides to us shareholders.
- Where is Brad?
- Where is Sorrentino?
- Where is the board of directors?
Where is their RESPONSIBILITY to represent shareholders?
-----------------------------------------------------
1. When is Sorrentino going to be announced? This has been posted on this board for months.
For it to have gained so much traction, there must have been some truth to this specilation?
2. From the 10k notification on the Pre-IND on Osteoarthritis, has the company submitted the IND?
(this now 7 months old? What action has been taken?)
Right out of the 10K:
"The Company submitted documentation to begin the process of filing the IND on October 30, 2020, in which CoreCyte is indicated for the treatment of osteoarthritis of the knee.
On December 29, 2020, the FDA completed the Pre-IND meeting. The Company is in the process of completing its IND application and submitting to the FDA."
3. What about "Other Events" from the 10K? Is the Nebula deal done? Shouldn't we get getting an update?
On May 7, 2021, the Company entered into a strategic collaboration and development agreement (the "Agreement") with Nebula Genomics ("Nebula"). Under the terms of the agreement, the Company may offer Nebula products to its customers, including 30x whole genome sequencing testing, analytical tools, and other products, which are fulfilled by Nebula. The Company will have a revenue sharing agreement with Nebula for each product ordered by its customers.
Nebula will provide the Company with technologies and services to assist it in direct to consumer and clinical diagnostic markets in the areas of privacy technologies, such as block chain, and analytical tools. Nebula will provide access to its 30x whole genome sequencing capabilities. In addition, the Company and Nebula intend to pursue joint development of proprietary diagnostics by leveraging assets, expertise, and development platforms. These development activities will be governed by joint scientific advisory boards with representation from both companies
My belief, is they could split this company up in a couple ways and still have more value in each of the resulting entities than we have today.
So what's the deal here….....I've paid 30-50 cents for this stock when a PDF on the company circulated last year and the company went to 65+ cents a share.
The names, the people that are affiliated seem to be tremendous.
Fast Forward:
1. The website shows significant mining assets? (Billions by their own estimation - aren't metals more valuable now?)
2. A soccer team? People on this board said in France.
3. Access to money? Clarinova bond expires next year, is it being replaced? Read the website
4. Movies, media and more? Just look at the people involved? Why would they be here otherwise? "EMG is working to launch the Element Networks, a global proprietary streaming platform" Right off their website.
What is a company like this worth? $1, $2, $5 or more, prior posts say just one property is worth $17/share.
People should start to dump all the marketing and collateral that has been made available the last two years. If only 10% of it is true, this is an absolute monster!!!!
What are we waiting for?
- How long does it take Sonny to discuss with Merle the deal parameters and get this moving????
- Friends were told the bond was done a year ago, now being told bond is awaiting final stuff. Clarinova had the money years ago? or not? No idea?
Anything less than a 1:1 ratio and this will be ballistic.......how could somebody put meaningful assets into a shell and the shell makes out? I would argue that ELGL shareholders should get 2 shares BFNH for every 1 share ELGL.
BFNH is not a NASDAQ-listed SPAC with millions of dollars, let's call it for what it is - A SHELL with shell risk. That's it.
The value is with ELGL and therefore, ELGL shareholders need to prosper.
What are we waiting for?
- How long does it take Sonny to discuss with Merle the deal parameters and get this moving????
- Friends were told the bond was done a year ago, now being told bond is awaiting final stuff. Clarinova had the money years ago? or not? No idea?
Anything less than a 1:1 ratio and this will be ballistic.......how could somebody put meaningful assets into a shell and the shell makes out? I would argue that ELGL shareholders should get 2 shares BFNH for every 1 share ELGL.
BFNH is not a NASDAQ-listed SPAC with millions of dollars, let's call it for what it is - A SHELL with shell risk. That's it.
The value is with ELGL and therefore, ELGL shareholders need to prosper.
This post seems irresponsible and inaccurate. My understanding is the debt was converted to stock. The relationship among PRED is good.
This is not a rumor but an actual response from IR at PRED.
Predictive Technology Group, Inc. (PRED) continues to move forward on all fronts. The Company’s Stem Cell business improving greatly since non-essential doctor offices reopening across USA, and PRED should have a medical research journal report out soon regarding the BETA testing program on the ART Guide and Fertility DX woman test products. The Company’s collaborative agreements with both Thermal Fischer – women health products and Atrin Pharmaceutical -novel cancer treatments continue to grow themselves.
“Assurance AB” COVID-19 kits arrived into the USA from Jiangsu Dablood Pharmaceutical CO, LTD ( Dablood), its manufacturing partner in CHINA, under the CLIA EUA provision of the FDA. And, the inventory of kits available at our office/lab in Salt Lake City, UT can fill orders, accordingly.
The FDA approval for individual distribution of the serology test kits without going to a CLIA certified lab (https://www.cdc.gov/clia/index.html) remains pending. The National Cancer Institute, the organization within the FDA, is the responsible entity working with PRED on the approval for individual point-of-care administration. So, as of now, PRED has no way of getting COVID 19 serology kits out individually, and currently, all kits can be sold into the market to other labs and medical practitioners per FDA rules under the CLIA affiliation program under the EUA (https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization).
When PRED became suspended, it lost its 211 status with FINRA. So, the Company currently trades on the "GREY Market," a market platform which limits market participation due to the fact a vast majority of brokers don't make markets in "GREY" listed equities. Once the Company regains its 211 status, the Company can once again trade on the "OTCMARKETS" platform as it was prior to its US SEC suspension. Or, if possible a more senior exchange, if PRED meets the market conditions to list, as such.
When FINRA approves a 15c-211 application, the Company can move off the Grey; PRED cannot give a timetable on this approval because FINRA doesn’t proved such guidance.
Here is the most recent public filing, the 10-Q report for the nine months ending March 31, 2020, filed on May 15, 2020:
https://www.sec.gov/Archives/edgar/data/1382943/000109181820000125/pred05142020form10qmarch.htm
The next financial report, 10-K, the year-end June 30, 2020, expected to be filed on or before September 28, 2020.
The board, the management team, the employee and professional service providers, all continue to put in 60-70 hours per week for the betterment of PRED, its shareholders and its operations. And, when material information becomes available regarding the Company's operations, then that information to be published according to the rules /regulations stipulated by the US SEC.
Maz - to clarify.
What Kaiser meant by the EUA, is that there is an open EUA for CLIA labs to provide test kits to other CLIA labs or Healthcare facilities (Hospitals, State Agencies, etc) So they can sell the Dablood test kits, but not to everyone - not yet.
The Dablood specific EUA has "not yet" been approved by the FDA, by way of the National Cancer Institute. Once they get this specific EUA, they would also qualify for the Federal reimbursement programs. (Like $100/test - or the people they sell the test kits can get the $100 reimbursement - either way, they can sell a lot of test kits)
All-in-all, PRED needs to get a sense of urgency with completing tasks. They are slow to react, slow to get tests flowing, but there is still time to make a lot of money.
I see a pathway for them to do over $30 million this quarter, (ending September 30th) but they need to execute much better. The last 4 months have been a shit show for a multitude of reasons - the biggest being the inability to get tests flowing, the blame being a lack of cash to get tests flowing. (if they had not burned through 10's of millions, they should have had some money to purchase tests??)
Interesting video about Predictive today.
Wonder if the rumor will be proven accurate or not? If this rumor is true and and he failed to perform any due dilegence... failed to see that they filed an 8k... what possible reason could he have had?
1. Too lazy to do his job properly?
2. Too stupid and inept to do his job properly?
3. Possible financial gain from initiating the suspension (like Birdman said)?
4. Thought it was a good idea to put his faith in unscrupulous writings?
What other reasons could someone at the SEC have for jeopardizing people's livelihoods and investments by suspending a company without proper due diligence that goes above and beyond reason.
Interesting link here as well. 1:15 into the video is interesting.
Is it true that Lee Buck from the SEC claimed he didn't know Predictive filed an 8k for approval before making announcements?
I have read that there have been complaints filed against the Hindenburg. Has anyone filed a complaint against Nate Anderson?
http://www.clarityspring.com/about-us/
Thank you, sir.
Thank you Needsome. This move by you is absolutely spectacular.
I will be following the lead and filing with the SEC as well. Over the past year I have taken screen shots of many posts; many before they were able to be deleted.
PRED is covered!!!!!!!
Look up DaAn Gene in China. Look up the subsidiaries under DG.......one of them begins with Zh........then look again at the Chinese list and see if you can find a match.
Specificity is crucial as it eliminates false readings. To put Predictive's AssuranceAB (92% accuracy) in perspective... pregnancy tests have accuracy rates as low as 85%.
https://www.verywellfamily.com/home-pregnancy-tests-906656
I thought she was here for research.
Needsome,
You've got some great ideas. Flipping burgers all these years has definitely given you time to think and develop your plans.
When this epidemic subsides I look forward to seeing your grilling skills at the bbq.
Needsome, if this is true, would it be possible to monetize the repeated usage of the tests? How many times would the average working person need testing throughout the year?
This test is so easy a caveman could do it!
Elk, that was not mercy buying. Do you have any idea what actually transpired at the close?
No one wants to be short this weekend!
I'm sure we all have been thinking about the benefits of what these contracts would bring the company and the tremendous doors it would open as a result of the revenue.
Calculations based on the number of tests being requested by politicians are truly staggering.
If this can come to fruition RL will be working at the Bunny Ranch and not visiting.
You are clearly reaching with your statements. Pred is about to pop and everyone knows it.
It will be very interesting to hear RL tomorrow!
BIG NEWS!!!
That would be fantastic if it were true! However, are you certain it was stem cells they're working on?
https://www.scmp.com/news/china/society/article/3053080/coronavirus-critically-ill-chinese-patient-saved-stem-cell
Coronavirus: critically ill Chinese patient saved by stem cell therapy, study says
65-year-old woman in Kunming hospital intensive care unit showed no adverse effects to her first shot and after two was up and walking again, researchers say
Results ‘could be very important and inspire similar clinical practices in treating critically ill Covid-19 patients’
Maybe its a good idea if you take your financial advisor's advice. I'm hoping you do.
I'm new to this forum as well and have owned the stock for over a year. Signed up not because of the HB but because of Needsome's enlightening posts.
Needsome is on fire with these posts!